029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FOV1005c卵巢疾病谱组织组合芯片(WHO+2014版),附病理分级、TNM和临床分期,100例/100点,替代OV1005b
点 数100例 数100
行 数10列 数10
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FOV1005c
 
卵巢疾病谱组织组合微阵列芯片,包含浆液性癌27例,粘液性腺癌3例,子宫内膜样癌10例,恶性Brenner瘤5例,+转移癌10例,交界性肿瘤7例,腺瘤18例,边缘卵巢组织19例,卵巢组织1例,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ova
-Ovary
Per
-Peritoneum
Gre
-Greater omentum
Mes
-Mesentery
 
Benign (*)
 
Borderline (*)
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIIB)
 
Malignant (IIIC)
 
Metastasis (*)
 
Metastasis (IIIA)
 
NAT (*)
 
Normal (*)
TISSUE  ARRAYS FOV1005c
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
MES
MES
GRE
GRE
GRE
F
GRE
GRE
GRE
PER
PER
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
I
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
J
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1138FOvaryLow grade serous carcinoma*T3cN1M0IIICMalignantN
A2237FOvaryLow grade serous carcinoma*T1N0M0IMalignantN
A3350FOvaryLow grade serous carcinoma*T2N0M0IIMalignantN
A4422FOvaryLow grade serous carcinoma*T2bN0M0IBMalignantN
A5526FOvaryLow grade serous carcinoma*T1cN0M0ICMalignantN
A6679FOvaryHigh grade serous carcinoma*T1aN0M0IAMalignantN
A7750FOvaryHigh grade serous carcinoma*T1bN0M0IBMalignantN
A8851FOvaryHigh grade serous carcinoma*T3cN1M0IIICMalignantN
A9948FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
A101026FOvaryHigh grade serous carcinoma*T3cN1M0IIICMalignantN
B11158FOvaryHigh grade serous carcinoma (sparse)*T1N0M0IMalignantN
B21256FOvaryHigh grade serous carcinoma*T2N1M0IIICMalignantN
B31351FOvaryHigh grade serous carcinoma*T1aN0M0IAMalignantN
B41452FOvaryHigh grade serous carcinoma*T2N0M0IIMalignantN
B51554FOvaryHigh grade serous carcinoma*T3cN1M0IIICMalignantN
B61633FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
B71749FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
B81841FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
B91950FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
B102052FOvaryHigh grade serous carcinoma*T1aN0M0IAMalignantN
C12157FOvaryHigh grade serous carcinoma*T3cN1M0IIICMalignantN
C22256FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
C32354FOvaryRelapsed high grade serous carcinoma*T3cN0M0IIICMalignantN
C42449FOvaryHigh grade serous carcinoma*T2N0M0IIMalignantN
C52548FOvaryHigh grade serous carcinoma*T1N0M0IMalignantN
C62652FOvaryHigh grade serous carcinoma*T2N0M0IIMalignantN
C72747FOvaryHigh grade serous carcinoma*T3cN1M0IIICMalignantN
C82863FOvaryMucinous carcinoma*T1aN0M0IAMalignantN
C92969FOvaryMucinous carcinoma*T1bN0M0IBMalignantN
C103034FOvaryMucinous carcinoma*T1bN0M0IBMalignantN
D13146FOvaryEndometrioid carcinoma*T2N0M0IIMalignantN
D23255FOvaryEndometrioid carcinoma*T1N0M0IMalignantN
D33347FOvaryEndometrioid carcinoma*T2aN0M0IAMalignantN
D43454FOvaryEndometrioid carcinoma*T1bN0M0IBMalignantN
D53555FOvaryEndometrioid carcinoma*T1N0M0IMalignantN
D63656FOvaryEndometrioid carcinoma*T1aN0M0IAMalignantN
D73743FOvaryEndometrioid carcinoma*T1cN0M0ICMalignantN
D83847FOvaryEndometrioid carcinoma*T1cN0M0ICMalignantN
D93953FOvaryEndometrioid carcinoma*T2aN0M0IAMalignantN
D104050FOvaryEndometrioid carcinoma*T3bN0M0IIIBMalignantN
E14151FOvaryMalignant Brenner tumor*T1bN0M0IBMalignantN
E24239FOvaryMalignant Brenner tumor*T1aN0M0IAMalignantN
E34338FOvaryMalignant Brenner tumor*T1N0M0IMalignantN
E44466FOvaryMalignant Brenner tumor*T1aN0M0IAMalignantN
E54553FOvaryMalignant Brenner tumor*T1N0M0IMalignantN
E64647FMesenteryMetastatic adenocarcinoma from ovary2T3aN0M0IIIAMetastasisN
E74759FMesenteryMetastatic adenocarcinoma from ovary3**MetastasisN
E84828FGreater omentumMetastatic adenocarcinoma from ovary2**MetastasisN
E94965FGreater omentumMetastatic adenocarcinoma from ovary2**MetastasisN
E105064FGreater omentumMetastatic adenocarcinoma from ovary2**MetastasisN
F15150FGreater omentumMetastatic adenocarcinoma from ovary2**MetastasisN
F25257FGreater omentumMetastatic adenocarcinoma from ovary2**MetastasisN
F35358FGreater omentumMetastatic adenocarcinoma from ovary2**MetastasisN
F45447FPeritoneumMetastatic adenocarcinoma from ovary3**MetastasisN
F55549FPeritoneumMetastatic adenocarcinoma from ovary3**MetastasisN
F65634FOvaryBorderline serous tumor***BorderlineN
F75728FOvaryBorderline serous tumor***BorderlineN
F85830FOvaryBorderline serous tumor***BorderlineN
F95934FOvaryBorderline serous tumor***BorderlineN
F106022FOvaryBorderline mucinous tumor***BorderlineN
G16150FOvaryBorderline mucinous tumor***BorderlineN
G26237FOvaryBorderline mucinous tumor***BorderlineN
G36358FOvarySerous papillary cystadenoma***BenignN
G46422FOvarySerous cystadenoma***BenignN
G56549FOvarySerous cystadenoma***BenignN
G66639FOvarySerous cystadenoma***BenignN
G76716FOvarySerous cystadenoma (fibrous tissue and blood vessel)***BenignN
G86862FOvarySerous cystadenoma***BenignN
G96928FOvarySerous cystadenoma***BenignN
G107018FOvaryMucinous cystadenoma***BenignN
H17129FOvaryMucinous cystadenoma (fibrous tissue and blood vessel)***BenignN
H27255FOvaryMucinous cystadenoma***BenignN
H37326FOvaryMucinous cystadenoma***BenignN
H47470FOvaryMucinous cystadenoma (fibrous tissue, blood vessel and mucus)***BenignN
H57522FOvaryMucinous cystadenoma***BenignN
H67633FOvaryMucinous cystadenoma***BenignN
H77738FOvaryMucinous cystadenoma***BenignN
H87851FOvaryMucinous cystadenoma***BenignN
H97934FOvaryMucinous cystadenoma***BenignN
H108035FOvaryMucinous cystadenoma***BenignN
I18145FOvaryAdjacent normal ovary tissue***NATN
I28245FOvaryAdjacent normal ovary tissue***NATN
I38340FOvaryAdjacent normal ovary tissue***NATN
I48442FOvaryAdjacent normal ovary tissue***NATN
I58540FOvaryAdjacent normal ovary tissue***NATN
I68650FOvaryAdjacent normal ovary tissue***NATN
I78740FOvaryAdjacent normal ovary tissue***NATN
I88840FOvaryAdjacent normal ovary tissue***NATN
I98942FOvaryAdjacent normal ovary tissue***NATN
I109048FOvaryAdjacent normal ovary tissue***NATN
J19150FOvaryAdjacent normal ovary tissue***NATN
J29241FOvaryAdjacent normal ovary tissue***NATN
J39342FOvaryAdjacent normal ovary tissue***NATN
J49442FOvaryAdjacent normal ovary tissue***NATN
J59551FOvaryAdjacent normal ovary tissue***NATN
J69645FOvaryAdjacent normal ovary tissue***NATN
J79738FOvaryAdjacent normal ovary tissue***NATN
J89838FOvaryAdjacent normal ovary tissue***NATN
J99952FOvaryAdjacent normal ovary tissue***NATN
J1010054FOvaryOvary tissue***NormalN
K1101N
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情